Nova Patents
HUE044352T2

Pertuzumab, trastuzumab, docetaxel and carboplatin for the treatment of early-stage breast cancer

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

140 members in 33 offices

This recordMember, by publication datePriority claim23 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
201161547535United States of AmericaP
201161567015United States of AmericaP
201261657669United States of AmericaP
201261682037United States of AmericaP
201261694584United States of AmericaP

Members140

Family members, oldest first
DocumentOfficeKind
CA2788253A1CanadaA1
CA3104165A1CanadaA1
CA3167799A1CanadaA1
US2013095172A1United States of AmericaA1
WO2013055874A2World Intellectual Property Organization (WIPO)A2
WO2013055874A3World Intellectual Property Organization (WIPO)A3
AU2012322797A1AustraliaA1
IL231350A0IsraelA0
IL231350D0IsraelD0
MX2014004021AMexicoA
CR20140170ACosta RicaA
SG11201401432XASingaporeA
KR20140075725ARepublic of KoreaA
AU2012322797A8AustraliaA8
PH12014500733A1PhilippinesA1
CL2014000889A1ChileA1
EP2766040A2European Patent Office (EPO)A2
JP2014530235AJapanA
PE20142363A1PeruA1
CN104334189AChinaA
IN2703CHN2014AIndiaA
HK1202242AHong Kong, ChinaA
HK1202242A1Hong Kong, ChinaA1
EA201490779A1Eurasian Patent Organization (EAPO)A1
AU2012322797B2AustraliaB2
NZ621367ANew ZealandA
US2016175438A1United States of AmericaA1
AU2016204962A1AustraliaA1
SG10201606756PASingaporeA
KR20170023195ARepublic of KoreaA
BR112014007521A2BrazilA2
JP2017222663AJapanA
UA116095C2UkraineC2
AU2016204962B2AustraliaB2
BR112014007521A8BrazilA8
AU2018203970A1AustraliaA1
ZA201401259BSouth AfricaB
NZ732854ANew ZealandA
US2019117769A1United States of AmericaA1
EP2766040B1European Patent Office (EPO)B1
CN109908341AChinaA
PT2766040TPortugalT
PH12014500733B1PhilippinesB1
DK2766040T3DenmarkT3
LT2766040TLithuaniaT
RS58944B1SerbiaB1
SI2766040T1SloveniaT1
EA201991164A1Eurasian Patent Organization (EAPO)A1
MX2019009153AMexicoA
HRP20191247T1CroatiaT1
HUE044352T2This recordHungaryT2
AU2018203970B2AustraliaB2
MY172326AMalaysiaA
AU2019261666A1AustraliaA1
PL2766040T3PolandT3
ES2736005T3SpainT3
EP3598981A2European Patent Office (EPO)A2
EA034390B1Eurasian Patent Organization (EAPO)B1
JP6646785B1JapanB1
JP2020033353AJapanA
KR102099991B1Republic of KoreaB1
ZA201701050BSouth AfricaB
EP3598981A3European Patent Office (EPO)A3
JP2020090507AJapanA
US2020206348A1United States of AmericaA1
NZ750877ANew ZealandA
US2020376120A1United States of AmericaA1
US2021015919A1United States of AmericaA1
CA2788253CCanadaC
UA123092C2UkraineC2
PH12019500519A1PhilippinesA1
AU2019261666B2AustraliaB2
SG10202110077QASingaporeA
IL286921AIsraelA
JP2022062010AJapanA
CN114984205AChinaA
US2022362379A1United States of AmericaA1
MY194408AMalaysiaA
CA3104165CCanadaC
KR102502545B1Republic of KoreaB1
KR20230028585ARepublic of KoreaA
IL231350B1IsraelB1
IL301603AIsraelA
KR20230073340ARepublic of KoreaA
CN116236569AChinaA
CN116271011AChinaA
CN116271013AChinaA
CN109908341BChinaB
JP7303957B1JapanB1
CA3167799CCanadaC
IL231350B2IsraelB2
JP2023109779AJapanA
JP2023109780AJapanA
EP4234033A2European Patent Office (EPO)A2
EP4234034A2European Patent Office (EPO)A2
US2023277663A1United States of AmericaA1
US2023277664A1United States of AmericaA1
EP4241849A2European Patent Office (EPO)A2
EP4234033A3European Patent Office (EPO)A3
EP4234034A3European Patent Office (EPO)A3
Showing 100 of 140